<DOC>
	<DOCNO>NCT01098812</DOCNO>
	<brief_summary>The aim study : - Demonstrate reduction postoperative cylinder compare result control lens - Demonstrate well uncorrected distance visual acuity compare control lens</brief_summary>
	<brief_title>Clinical Evaluation 1-Piece Intraocular Lens</brief_title>
	<detailed_description />
	<mesh_term>Cataract</mesh_term>
	<criteria>Minimum 18 year age Cataract phacoemulsification extraction posterior chamber IOL implantation plan eye Preoperative best correct distance visual acuity ( BCDVA ) 20/40 worse ( Snellen ) , without glare , eye BCDVA project good 20/30 follow cataract removal IOL implantation eye Preoperative keratometric cylinder 0.75 diopter 3.62 diopter eye ( exception second eye 0.00.75 diopter plan receive nontoric IOL ) Clear intraocular medium cataract eye Availability , willingness , ability sufficient cognitive awareness comply examination procedure study visit Signed informed consent HIPAA authorization Requiring IOLs outside spherical power range +15.0 +28.0 diopter Dilated pupil size le 5.5 mm presence pupil abnormality ( nonreactive , fix pupil , abnormally shape pupil ) either eye Previous corneal intraocular surgery either eye Irregular corneal astigmatism either eye Corneal pathology/abnormality potentially affect topography either eye Corneal abnormalities stromal , epithelial endothelial dystrophy either eye Inability achieve keratometric stability either eye contact lens wearer Subjects diagnose degenerative visual disorder either eye ( eg. , macular degeneration retinal disorder ) predict cause future acuity loss level 20/30 bad Subjects condition associate increase risk zonular rupture , include capsular zonular abnormality may lead IOL decentration , include pseudoexfoliation , trauma , posterior capsule defect An eccentric anterior capsulorhexis , zonular damage/rupture capsular tear/rupture cataract extraction procedure Use systemic ocular medication may affect vision Prior , current , anticipated use course nine month study tamsulosin silodosin ( e.g. , Flomax , Flomaxtra , Rapaflo ) likely affect dilation iris structure Poorlycontrolled diabetes Acute , chronic , uncontrolled systemic disease illness would , opinion investigator , increase operative risk confound outcome ( ) study ( e.g. , immunocompromised , connective tissue disease , etc . ) Uncontrolled ocular hypertension glaucomatous change retina visual field either eye Known ocular disease pathology may affect visual acuity may require surgical intervention course study ( macular degeneration , cystoid macular edema , diabetic retinopathy , etc . ) Patient pregnant , plan become pregnant , lactate another condition associate fluctuation hormone could lead refractive change Concurrent participation participation 30 day prior preoperative visit clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Cataract , Intraocular lens</keyword>
</DOC>